Drug firm, Aurobindo Pharma has reported consolidated net loss of Rs 28.54 crore for the quarter ended December 31, 2011, against net profit of Rs 188.63 crore for the corresponding period last fiscal. The group’s consolidated net sales rose by 7.74% to Rs 1,284.51 crore during the quarter under review from Rs 1,192.20 crore in the year-ago period.
On a standalone basis, the company posted a net profit of Rs 12.93 crore for the third quarter ended December 31, 2011, as against Rs 183.85 crore in the same period last fiscal. Net sales rose by 3.88% to Rs 1,201.50 crore during the quarter under review from Rs 1,156.61 crore in the year-ago period.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: